e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Prognosis of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of haptogobins genetically determined phenotypes in the development, treatment and prevention pulmonary tuberculosis
K. Mazhak, O. Tkach (Ukraine)
Source:
Annual Congress 2010 - Prognosis of tuberculosis
Session:
Prognosis of tuberculosis
Session type:
Thematic Poster Session
Number:
3102
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Mazhak, O. Tkach (Ukraine). Role of haptogobins genetically determined phenotypes in the development, treatment and prevention pulmonary tuberculosis. Eur Respir J 2010; 36: Suppl. 54, 3102
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Frequency of development acquired drug resistance in successful treated patients with newly detected pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002
Effects of complex treatment with izofon of a pulmonary tuberculosis in children
Source: Eur Respir J 2004; 24: Suppl. 48, 652s
Year: 2004
Endobrochites of specific genesis in patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 201s
Year: 2004
Frequently used inflammation markers and their role in monitoring tuberculosis treatment
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008
Role of different risk factors in development of recurrent tuberculosis of the lungs in conditions of Uzbekistan
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009
Role of surgery in treating of firstly-found destructive pulmonary tuberculosis after ineffective DOTS-therapy
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Impact of mono- and poli-resistance on the treatment outcomes of pulmonary tuberculosis
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
The peculiarities of course and treatment of pulmonary tuberculosis with initial drug resistance
Source: Eur Respir J 2003; 22: Suppl. 45, 41s
Year: 2003
Association of genetic markers with clinical course of patients with pulmonary tuberculosis with drug resistance
Source: Eur Respir J 2007; 30: Suppl. 51, 203s
Year: 2007
Treatment outcome of MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008
Aspects of diagnosis and treatment in pulmonary tuberculosis in children
Source: Eur Respir J 2002; 20: Suppl. 38, 168s
Year: 2002
Pulmonary function following treatment for pulmonary tuberculosis
Source: Annual Congress 2006 - Epidemiology and control of tuberculosis
Year: 2006
Rimfampicin importance in tuberculosis treatment
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008
Pulmonary tuberculosis
Source: Respipedia Article
Year: 2018
Treatment results in patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002
Diagnosis and treatment delay in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003
Severe pulmonary hypertension in lung disease: phenotypes and response to treatment
Source: Eur Respir J 2015; 46: 1378-1389
Year: 2015
Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease
Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017
Year: 2018
Non-pharmacological factors for the emergence of drug resistance in patients of pulmonary tuberculosis: An Indian overview
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Pyrosequencing(PSQ) in early diagnosis of CNS tuberculosis and determining drug resistance.
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept